Aarti Drugs Ltd reports Q2 FY27 revenue of ₹826.2 crore, up 27% YoY, and net profit of ₹82.8 crore, up 83%.
- EBITDA rose 63% YoY to ₹137.9 crore; margin expanded 370 bps to 16.6%.
- Revenue increased 18% sequentially; EBITDA rose 42% and net profit 65% QoQ.
- PAT margin was 10.0%.